Refine by
Cancer Patient Suppliers & Manufacturers
175 companies found
based inGangnam-gu, SOUTH KOREA
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...
based inAlbuquerque, NEW MEXICO (USA)
Indica Labs is the world’s leading provider of computational pathology software and services. Our flagship HALO image analysis platform enables fast, quantitative evaluation of tissues using a broad range of artificial intelligence (AI) and computer ...
HALO AI is a collection of train-by-example classification and segmentation tools underpinned by advanced deep learning neural network algorithms. HALO AI classifiers can be trained to quantify tissue classes, to segment tissue classes for analysis ...
based inAhrensburg, GERMANY
The biotechnology company Abviris Deutschland GmbH, based in Ahrensburg, Germany, is a pioneer in HPV serology, developing innovative, next generation, products such as Prevo-Check® for early detection and post-treatment monitoring of HPV-induced ...
based inSanta Clara, CALIFORNIA (USA)
Filtricine, Inc. is a clinical stage biotechnology company focused on developing novel products for cancer management. We are backed by venture capital and located in the San Francisco Bay Area of California. We are developing an innovative way to ...
based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
based inMelville, NEW YORK (USA)
FONAR was incorporated in 1978, making it the first, oldest and most experienced MR manufacturer in the industry. FONAR introduced the world's first commercial MRI (a whole-body MRI scanner) in 1980, and went public in 1981. In 1982, FONAR ...
based inIsfiya, ISRAEL
At Check-Cap our experienced and motivated team is committed to increasing screening adherence and helping to reduce the global incidence of colorectal cancer (CRC) through cancer prevention. Our patented technology C-Scan is the first and only ...
based inChangning District, CHINA
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative ...
based inSesto Fiorentino (FI), ITALY
Imaginalis began as an innovative start-up in Calenzano (FI) in 2013, with the aim of using its innate aptitude for human and veterinary interventional radiology to develop cutting-edge technology for the medical diagnostics industry. Imaginalis is ...
With its HU and GT-30 series machines, Imaginalis has reached the highest levels of flat-panel CT technology, overcoming the boundaries that often come with scanning hard ...
based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
Opaganib (ABC294640) is a first-in-class, proprietary sphingosine kinase-2 (SK2) selective inhibitor, administered orally, with anticancer, anti-inflammatory and anti-viral ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
Lumin Bioinformatics is a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The power of Lumin is in the ability to ...
based inLouvain-La-Neuve, BELGIUM
At IBA we dare to develop innovative solutions pushing back the limits of technology. We share ideas and know-how with our customers and our partners to bring new solutions for the diagnosis and treatment of cancer. We care about the well-being of ...
Proteus® has been inspired by everyday clinical practice. Through day-to-day interactions with the community, IBA is perfectly positioned to understand, and invest in, the user’s needs. These investments are directly translated into ...
based inHouston, TEXAS (USA)
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. GP2 is derived ...
Cancer Immunotherapies are a New Method of Cancer Treatment. Among the more established treatment options, such as surgery, chemotherapy, targeted therapy, and radiation therapy, cancer ...
based inEpalinges, SWITZERLAND
AC BioScience Ltd., a clinical-stage biotech company and a developer of immune modulating and angiogenic cancer therapies. AC BioScience LTD. is a Swiss biotech company, pioneering the development of novel therapies in immuno-oncology and tumor ...
based inRockville, MARYLAND (USA)
Creatv MicroTech is a privately-held company, founded by Dr. Cha-Mei Tang, which specializes in microfabrication and biodetection. The company’s business is based on cutting-edge research and development - leveraging our expertise in the sciences ...
based inChuo-ku, JAPAN
Sysmex has a global network of operations throughout the world. This section introduces our company profile and provides the locations of our offices and subsidiaries. Sysmex supports human health. We are an integrated company, developing and ...
In general, gene amplification (such as the RT-PCR method) reaction requires a process to prevent impurities in the sample from affecting the gene amplification reaction. Also, it takes more than one hour for the gene amplification reaction. Sysmex ...
based inMont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
based inTucson, ARIZONA (USA)
D3Sciences is dedicated to the development of tools for improved tissue sampling to expand cancer diagnosis, therapy specificity, and research. Creating tools to improve tissue sampling for rapid, precise, and cost effective delivery of care to ...
Detecting, Diagnosing and Treating Cancer: To detect, diagnose, and treat internal cancer requires a team of healthcare providers led generally by three specialist physicians: oncologists, radiologists, and ...
based inLondon, UNITED KINGDOM
Vision RT provides innovative Surface Guided Radiation Therapy (SGRT) solutions for cancer treatment. Vision RT was founded in 2001 with a mission to develop pioneering technology for Surface Guided Radiation Therapy (SGRT), with the goal of ...
based inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
